In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B

Abraham, O. C.;Manavathu, E. K.;Cutright, J. L.;Chandrasekar, P. H.

Author address: 

Manavathu, EK, Wayne State Univ, Dept Internal Med, Sch Med, Dept Med,Div Infect Dis, 427 Lande Bldg,550 E Canfield, Detroit, MI 48201 USA

Abstract: 

We studied the in vitro activity of voriconazole (VCZ) itraconazole (ITZ) and amphotericin B (AMB) against 216 clinical isolates of Aspergillus spp. (142 Aspergillus fumigatus and 74 nonfumigatus Aspergillus spp. isolates) using a broth macrodilution method. The MICs (mu g/mL) (mean, range) for A. fumigatus were: VCZ 0.88, 0.25-4; ITZ 0.54, 0.25-4; AMB 2.16, 0.5-8. MIC(90)s were: VCZ 2, ITZ 1, AMB 4. MICs for nonfumigatus Aspergillus spp. were: VCZ 1.57, 0.25-4; ITZ 1.74, 0.25-4; AMB 2.88, 0.5-8. MIC(90)s for this group were: VCZ 4, ITZ 4, AMB 4. We also studied the susceptibility to VCZ of 18 AMB-resistant (mean, MIC 6.0 mu g/mL) and 28 ITZ-resistant (mean, MIC 13.28 mu g/mL) A. fumigatus isolates selected in the laboratory. The mean MICs of VCZ were 0.59 mu g/mL for AMB- resistant and 1.32 mu g/mL for ITZ-resistant isolates. Our study showed that VCZ and ITZ had comparable in vitro activity against the isolates studied, except against A. fumigatus, where the MIC of ITZ was lower. The azoles had better in vitro activity than AMB against A. fumigatus and non-fumigatus spp. The non-fumigatus Aspergillus spp. were less susceptible to all three antifungals evaluated. When tested against ITZ- or AMB- resistant A. fumigatus strains, VCZ retained good activity, showing only a modest rise in the MIC against ITZ-resistant strains. (C) 1999 Elsevier Science Inc.
1997

abstract No: 

NULL

Full conference title: 

35th Annual Meeting of the Infectious-Diseases-Society-of- America
    • IDSA 35th